Literature DB >> 1376243

Agonist pharmacology of neonatal and adult glycine receptor alpha subunits: identification of amino acid residues involved in taurine activation.

V Schmieden1, J Kuhse, H Betz.   

Abstract

The inhibitory glycine receptor (GlyR) is a pentameric chloride channel protein which mediates postsynaptic inhibition in the mammalian central nervous system. In spinal cord, different GlyR isoforms originate from the sequential expression of developmentally regulated variants of the ligand binding alpha subunit. Here, neonatal alpha 2 and adult alpha 1 subunits are shown to generate GlyRs with distinct agonist activation profiles upon heterologous expression in Xenopus oocytes. Whereas alpha 1 receptors are efficiently gated by beta-alanine and taurine, alpha 2 GlyRs show only a low relative response to these agonists, which also display a reduced sensitivity to inhibition by the glycinergic antagonist strychnine. Construction of an alpha 2/alpha 1 subunit chimera and site-directed mutagenesis of the extracellular region of the alpha 1 sequence identified amino acid positions 111 and 212 as important determinants of taurine activation. Our results indicate the existence of distinct subsites for agonists on alpha 1 and alpha 2 GlyRs and suggest that the ligand binding pocket of these receptor proteins is formed from discontinuous domains of their extracellular region.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1376243      PMCID: PMC556667          DOI: 10.1002/j.1460-2075.1992.tb05259.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  35 in total

1.  Heterogeneity of glycine receptors and their messenger RNAs in rat brain and spinal cord.

Authors:  H Akagi; R Miledi
Journal:  Science       Date:  1988-10-14       Impact factor: 47.728

2.  Discrimination of heterogenous mRNAs encoding strychnine-sensitive glycine receptors in Xenopus oocytes by antisense oligonucleotides.

Authors:  H Akagi; D E Patton; R Miledi
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

3.  Monoclonal antibodies and peptide mapping reveal structural similarities between the subunits of the glycine receptor of rat spinal cord.

Authors:  F Pfeiffer; R Simler; G Grenningloh; H Betz
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

4.  UV light-induced cross-linking of strychnine to the glycine receptor of rat spinal cord membranes.

Authors:  D Graham; F Pfeiffer; H Betz
Journal:  Biochem Biophys Res Commun       Date:  1981-10-30       Impact factor: 3.575

5.  Photoaffinity-labelling of the glycine receptor of rat spinal cord.

Authors:  D Graham; F Pfeiffer; H Betz
Journal:  Eur J Biochem       Date:  1983-04-05

6.  Regional changes in amino acid content in developing rat brain.

Authors:  R W Cutler; D S Dudzinski
Journal:  J Neurochem       Date:  1974-11       Impact factor: 5.372

7.  What confers specificity on glycine for its receptor site?

Authors:  N Tokutomi; M Kaneda; N Akaike
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Amino acids of the Torpedo marmorata acetylcholine receptor alpha subunit labeled by a photoaffinity ligand for the acetylcholine binding site.

Authors:  M Dennis; J Giraudat; F Kotzyba-Hibert; M Goeldner; C Hirth; J Y Chang; C Lazure; M Chrétien; J P Changeux
Journal:  Biochemistry       Date:  1988-04-05       Impact factor: 3.162

10.  Glycine receptor heterogeneity in rat spinal cord during postnatal development.

Authors:  C M Becker; W Hoch; H Betz
Journal:  EMBO J       Date:  1988-12-01       Impact factor: 11.598

View more
  49 in total

1.  Microscopic kinetics and energetics distinguish GABA(A) receptor agonists from antagonists.

Authors:  M V Jones; P Jonas; Y Sahara; G L Westbrook
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

2.  Kinetic determinants of agonist action at the recombinant human glycine receptor.

Authors:  Trevor M Lewis; Peter R Schofield; Annette M L McClellan
Journal:  J Physiol       Date:  2003-04-04       Impact factor: 5.182

3.  Agonist action of taurine on glycine receptors in rat supraoptic magnocellular neurones: possible role in osmoregulation.

Authors:  N Hussy; C Deleuze; A Pantaloni; M G Desarménien; F Moos
Journal:  J Physiol       Date:  1997-08-01       Impact factor: 5.182

4.  Kinetic analysis of recombinant mammalian alpha(1) and alpha(1)beta glycine receptor channels.

Authors:  B Mohammadi; K Krampfl; C Cetinkaya; H Moschref; J Grosskreutz; R Dengler; J Bufler
Journal:  Eur Biophys J       Date:  2003-02-19       Impact factor: 1.733

5.  Differential agonist sensitivity of glycine receptor alpha2 subunit splice variants.

Authors:  Paul S Miller; Robert J Harvey; Trevor G Smart
Journal:  Br J Pharmacol       Date:  2004-08-09       Impact factor: 8.739

6.  Strychnine and taurine modulation of amygdala-associated anxiety-like behavior is 'state' dependent.

Authors:  Brian A McCool; Ann Chappell
Journal:  Behav Brain Res       Date:  2007-01-17       Impact factor: 3.332

7.  Taurine activates excitatory non-synaptic glycine receptors on dopamine neurones in ventral tegmental area of young rats.

Authors:  Fushun Wang; Cheng Xiao; Jiang Hong Ye
Journal:  J Physiol       Date:  2005-04-07       Impact factor: 5.182

Review 8.  Functional architecture of the nicotinic acetylcholine receptor: a prototype of ligand-gated ion channels.

Authors:  A Devillers-Thiéry; J L Galzi; J L Eiselé; S Bertrand; D Bertrand; J P Changeux
Journal:  J Membr Biol       Date:  1993-11       Impact factor: 1.843

9.  Defining affinity with the GABAA receptor.

Authors:  M V Jones; Y Sahara; J A Dzubay; G L Westbrook
Journal:  J Neurosci       Date:  1998-11-01       Impact factor: 6.167

10.  A cation-π interaction at a phenylalanine residue in the glycine receptor binding site is conserved for different agonists.

Authors:  Stephan A Pless; Ariele P Hanek; Kerry L Price; Joseph W Lynch; Henry A Lester; Dennis A Dougherty; Sarah C R Lummis
Journal:  Mol Pharmacol       Date:  2011-01-25       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.